Cellular Dynamics Signs Agreement With Nestle Institute of Health Sciences to Supply iCell(R) and MyCell(R) Products for Nutritional Research

8 januari 2014 MADISON, Wis., Jan. 8, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced signing a long-term supply agreement with the Nestlé Institute of Health Sciences SA (NIHS). Terms of the agreement were not disclosed. CDI's iCell® product line includes cardiomyocytes, neurons, hepatocytes, and endothelial cells, with numerous other cell types in development. The company's MyCell® Products are cell products manufactured from donor samples using iPSC technology to make stem cells or differentiated cells from any individual, including those with diseases of interest. "The ongoing work and this long-term supply agreement with NIHS demonstrate the utility and broad applicability of our iCell and MyCell Products," said Bob Palay, chief executive officer of CDI. "Our customers already benefit from a reliable supply of human iPSCs and human differentiated cells for their biomedical research and drug discovery. This supply agreement with NIHS adds nutritional research as yet another field that will benefit from CDI's products and expertise." About Cellular Dynamics International, Inc. Cellular Dynamics International, Inc. (CDI) is a leading developer of stem cell technologies for in vitro drug development, stem cell banking and in vivo cellular therapeutic research. CDI harnesses its unique manufacturing technology to produce differentiated tissue cells in industrial quality, quantity and purity from any individual's induced pluripotent stem cell line created from a standard blood draw. CDI was founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research at the University of Wisconsin-Madison. CDI's facilities are located in Madison, Wisconsin, with a second facility in Novato, California. See www.cellulardynamics.com. Follow us on Twitter @CellDynamics or www.twitter.com/celldynamics Forward-looking Statements This press release includes "forward-looking statements," including with respect to the proposed initial public offering and the Company's intended use of proceeds. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company's control. The forward- looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "will," "plan," "seek," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise. CONTACT: MEDIA CONTACTS:          Joleen Rau          Senior Director, Marketing & Communications          Cellular Dynamics International, Inc.          (608) 310-5142          jrau@cellulardynamics.com          Robert E. Flamm, Ph.D.          Russo Partners LLC          (212) 845-4226          robert.flamm@russopartnersllc.com          Investor Relations          Gitanjali Jain Ogawa          The Trout Group, LLC          (646) 378-2949          gogawa@troutgroup.com -------------------------------------------------------------------------------- This announcement is distributed by GlobeNewswire on behalf of GlobeNewswire clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Cellular Dynamics International, Inc. via GlobeNewswire [HUG#1753291]